首页AMLX • NASDAQ
add
Amylyx Pharmaceuticals Inc
昨日收盘价
$16.92
当日价格范围
$16.16 - $17.49
年度波幅
$2.61 - $17.49
市值
17.86亿 USD
平均交易量
184.91万
市盈率
-
股息率
-
主要交易所
NASDAQ
相关资讯
简介
Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis. AMX0035 was approved for medical use in Canada as Albrioza, in June 2022, and in the United States, as Relyvrio, in September 2022. It was withdrawn in April, 2024. Wikipedia
成立时间
2013
员工数量
123
